Visualitza per autor "Marmolejo Castañeda, David"
Ara mostrant els elements 1-4 d 4
-
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
Cedres Perez, Susana; Assaf, Juan David; Iranzo Gómez, Patricia; Callejo Perez, Ana; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Marmolejo Castañeda, David; Rezqallah Aron, Maria Alejandra; Amat, Ramon; Pedrola Gómez, Anna; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan; Dienstmann, Rodrigo (Nature Research, 2021-11-01) -
Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
Callejo Perez, Ana; Iranzo Gómez, Patricia; Diaz-Mejia, Nely; Marmolejo Castañeda, David; Assaf, Juan David; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Pardo Aranda, Nuria; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (MDPI, 2021-07) -
Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Current and Future Trends
Vega Cano, Kreina Sharela; Marmolejo Castañeda, David; Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina (MDPI, 2022-12-22) -
Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease
Suárez Rodríguez, Cristina; Marmolejo Castañeda, David; Valdivia Bustamante, Augusto Alejandro; Morales Barrera, Rafael; González Rodríguez, Macarena; Mateo Valderrama, Joaquim; Lorente García, David; Trilla Herrera, Enric; Carles Galceran, Joan; Semidey Raven, Maria Eugenia (Frontiers Media, 2022-10-04)